• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,578.00 586.78
( 0.76%)
Global Indices
Nasdaq
51,867.48 179.64
(0.35%)
Dow Jones
7,378.60 -7.86
(-0.11%)
Hang Seng
69,343.30 -445.08
(-0.64%)
Nikkei 225
10,453.87 25.02
(0.24%)
Forex
USD-INR
94.74 0.21
(0.22%)
EUR-INR
108.00 -0.19
(-0.17%)
GBP-INR
125.20 0.11
(0.09%)
JPY-INR
0.59 0.00
(0.26%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Transgene Biotek reports consolidated net loss of Rs 0.46 crore in the March 2026 quarter
May 30,2026
Net Loss of Transgene Biotek reported to Rs 0.46 crore in the quarter ended March 2026 as against net loss of Rs 0.71 crore during the previous quarter ended March 2025. Sales declined 37.50% to Rs 0.05 crore in the quarter ended March 2026 as against Rs 0.08 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 1.65 crore in the year ended March 2026 as against net loss of Rs 0.68 crore during the previous year ended March 2025. Sales declined 19.23% to Rs 0.21 crore in the year ended March 2026 as against Rs 0.26 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.050.08 -38 0.210.26 -19
OPM %-560.00-675.00 --257.14-430.77 -
PBDT-0.41-0.69 41 -1.45-0.58 -150
PBT-0.46-0.71 35 -1.65-0.68 -143
NP-0.46-0.71 35 -1.65-0.68 -143